Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (371)
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bozic Carmen — EVP and CMO
Shares
596
Price
$482.50
Total Value
$287.57K
Shares Held After
15,337
% of Holdings
3.7%
Vericel Corp (VCEL)
SIEGAL JONATHAN — Principal Accounting Officer
Shares
2,500
Price
$44.90
Total Value
$112.25K
Shares Held After
886
% of Holdings
73.8%
Vericel Corp (VCEL)
SIEGAL JONATHAN — Principal Accounting Officer
Shares
232
Price
$44.90
Total Value
$10.42K
Shares Held After
886
% of Holdings
20.8%
Vericel Corp (VCEL)
Hopper Jonathan Mark — Chief Medical Officer
Shares
5,000
Price
$45.00
Total Value
$225.00K
Shares Held After
75,753
% of Holdings
6.2%
Vericel Corp (VCEL)
Hopper Jonathan Mark — Chief Medical Officer
Shares
5,000
Price
$45.00
Total Value
$225.00K
Shares Held After
75,753
% of Holdings
6.2%
Vericel Corp (VCEL)
Flynn Sean C. — Chief Legal Officer
Shares
15,000
Price
$45.64
Total Value
$684.60K
Shares Held After
1,647
% of Holdings
90.1%
Vericel Corp (VCEL)
Mara Joseph Anthony Jr — Chief Financial Officer
Shares
5,000
Price
$44.75
Total Value
$223.75K
Shares Held After
16,009
% of Holdings
23.8%
Fulcrum Therapeutics, Inc. (FULC)
Ezekowitz Alan — Director
Shares
18,000
Price
$3.65
Total Value
$65.61K
Shares Held After
10,927
% of Holdings
62.2%
ProQR Therapeutics N.V. (PRQR)
Filius Bart — Director
Shares
150,000
Price
$1.54
Total Value
$231.00K
Shares Held After
150,000
% of Holdings
100.0%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
134
Price
$2.54
Total Value
$340.36
Shares Held After
2,469,083
% of Holdings
0.0%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
75,047
Price
$2.55
Total Value
$191.37K
Shares Held After
2,468,949
% of Holdings
3.0%
Roivant Sciences Ltd. (ROIV)
Sukhatme Mayukh — Director
Shares
500,000
Price
$34.08
Total Value
$17.04M
Shares Held After
18,677,617
% of Holdings
2.6%
Pharvaris N.V. (PHVS)
Lu Peng — Chief Medical Officer
Shares
14,700
Price
$34.00
Total Value
$499.85K
Shares Held After
65,631
% of Holdings
18.3%
ACADIA PHARMACEUTICALS INC (ACAD)
Kihara James — PRINCIPAL ACCOUNTING OFFICER
Shares
11,421
Price
$26.08
Total Value
$297.91K
Shares Held After
13,088
% of Holdings
46.6%
Zai Lab Ltd (ZLAB)
Edmondson Frazor Titus III — Chief Legal Officer
Shares
4,103
Price
$17.46
Total Value
$71.64K
Shares Held After
30,346
% of Holdings
11.9%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
24,543
Price
$17.46
Total Value
$428.55K
Shares Held After
1,192,840
% of Holdings
2.0%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
1,876
Price
$8.98
Total Value
$16.85K
Shares Held After
16,795,919
% of Holdings
0.0%
Zai Lab Ltd (ZLAB)
Chen Yajing — Chief Financial Officer
Shares
2,264
Price
$17.46
Total Value
$39.53K
Shares Held After
35,691
% of Holdings
6.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$553.49
Total Value
$22.14K
Shares Held After
40,513
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$552.36
Total Value
$154.66K
Shares Held After
40,553
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$550.79
Total Value
$220.32K
Shares Held After
40,833
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$549.69
Total Value
$285.84K
Shares Held After
41,233
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
872
Price
$548.90
Total Value
$478.64K
Shares Held After
41,753
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
452
Price
$548.13
Total Value
$247.75K
Shares Held After
42,625
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
156
Price
$547.00
Total Value
$85.33K
Shares Held After
43,077
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
560
Price
$545.52
Total Value
$305.49K
Shares Held After
43,233
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
439
Price
$544.18
Total Value
$238.89K
Shares Held After
43,793
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,012
Price
$543.32
Total Value
$549.84K
Shares Held After
44,232
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
983
Price
$542.14
Total Value
$532.93K
Shares Held After
45,244
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,128
Price
$541.24
Total Value
$1.15M
Shares Held After
46,227
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,018
Price
$539.89
Total Value
$549.61K
Shares Held After
48,355
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
640
Price
$538.34
Total Value
$344.54K
Shares Held After
49,373
% of Holdings
1.3%
Phio Pharmaceuticals Corp. (PHIO)
Bitterman Robert J — Director
Shares
10,000
Price
$0.99
Total Value
$9.90K
Shares Held After
421,421
% of Holdings
2.4%
Beam Therapeutics Inc. (BEAM)
FMR LLC — 10% Owner
Shares
251,488
Price
$35.26
Total Value
$8.87M
Shares Held After
854,583
% of Holdings
22.7%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
9,029
Price
$3.05
Total Value
$27.54K
Shares Held After
105,989
% of Holdings
7.9%
Immunovant, Inc. (IMVT)
Van Tuyl Christopher — Chief Legal Officer
Shares
2,842
Price
$38.96
Total Value
$110.72K
Shares Held After
180,597
% of Holdings
1.5%
Immunovant, Inc. (IMVT)
Van Tuyl Christopher — Chief Legal Officer
Shares
14,982
Price
$38.19
Total Value
$572.16K
Shares Held After
183,439
% of Holdings
7.6%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
100
Price
$26.39
Total Value
$2.64K
Shares Held After
33,054
% of Holdings
0.3%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
1,358
Price
$25.55
Total Value
$34.70K
Shares Held After
32,954
% of Holdings
4.1%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
4,212
Price
$24.90
Total Value
$104.88K
Shares Held After
31,596
% of Holdings
13.3%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
580
Price
$23.61
Total Value
$13.69K
Shares Held After
27,384
% of Holdings
2.1%
Immunovant, Inc. (IMVT)
Pande Atul — Director
Shares
1,500
Price
$38.01
Total Value
$57.02K
Shares Held After
116,731
% of Holdings
1.3%
Immunovant, Inc. (IMVT)
Girao Tiago — Chief Financial Officer
Shares
10,000
Price
$38.46
Total Value
$384.60K
Shares Held After
247,596
% of Holdings
3.9%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
6,723
Price
$38.94
Total Value
$261.79K
Shares Held After
211,685
% of Holdings
3.1%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
33,277
Price
$38.18
Total Value
$1.27M
Shares Held After
218,408
% of Holdings
13.2%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
2,966
Price
$38.95
Total Value
$115.53K
Shares Held After
224,393
% of Holdings
1.3%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
14,748
Price
$38.18
Total Value
$563.08K
Shares Held After
227,359
% of Holdings
6.1%
IONIS PHARMACEUTICALS INC (IONS)
Monia Brett P — Director
Shares
50,000
Price
$80.59
Total Value
$4.03M
Shares Held After
245,571
% of Holdings
16.9%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
191
Price
$56.27
Total Value
$10.75K
Shares Held After
134,215
% of Holdings
0.1%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
602
Price
$55.30
Total Value
$33.29K
Shares Held After
134,406
% of Holdings
0.4%
Showing 101–150 of 371 transactions (page 3 of 8)